Abstract:OBJECTIVE:To construct a recombinant adenovirus vector expressing TbetaR-II extracellular domain-RANTES fusion gene and evaluate its anti-tumor effects.METHODS:Mouse origin TbetaR-II extracellular domain and RANTES gene were amplified by RT-PCR. The TbetaR-II extracellular domain-RANTES fusion gene was amplified by overlapping PCR method. TbetaR-II extracellular domain-RANTES fusion gene was cloned into pDC316 vector. The recombinant adenovirus vector expressing the fusion gene was constructed by adMax adenovirus vector creation system. Recombinant adenovirus vector expressing the fusion gene was transfected into LA795 cells. The expression of recombinant adenovirus was checked by Westen blot. The levels of TGF-beta1, RANTES in supernatant were checked by ELISA. The transfected cells were counted and growth curve was obtained. Apoptosis of transfected cells was detected by Annexin V FITC method. The chemotactic activity of supernatant of transfected cells to splenic lymphocytes was assayed. Transfected cells (1 x 10(5)) were inoculated into T739 mice and to observe the tumor growth and survival time. Ad-TbetaR-II extracellular domain, Ad-RANTES and Ad-TbetaR-II extracellular domain-RANTES fusion gene(1 x 10(10) pfu) were injected into the tumor in T739 mice. The tumor size and tumor weight were recorded and tumor growth inhibition rate was counted and statistically analyzed.RESULTS:TbetaR-II extracellular domain and RANTES gene were amplified by RT-PCR and TbetaR-II extracellular domain-RANTES fusion gene amplified by overlapping PCR, were identified by DNA sequence analysis. Restriction enzyme digestion analysis showed that the recombinant vector was constructed correctly. The recombinant adenovirus vector expressing the fusion gene was constructed successfully using the AdMax Adenovirus Vector Creation System. Its titer was 8 x 10(10) pfu/ml. Ad-TbetaR-II extracellular domain-RANTES fusion gene was transfected into LA795 cells and had specific protein fragment proved by Western Blot. The concentration of TGF-beta1 was decreased and RANTES was increased in supernatant of transfected cells. The growth curve showed that recombinant adenovirus vector expressing the fusion gene could delay tumor development and induce apoptosis, with an apoptosis rate in vitro of 16.9%. The supernant of infected cells showed chemotactic activity to splenic lymphocytes. Tumor growth and survival time were prolonged significantly in group tranfected with recombinant adenovirus vector expressing the fusion gene, and tumor growth was effectively inhibited after injecting recombinant adenovirus vector expressing the fusion gene, with a tumor growth inhibition rate of 37.6%.CONCLUSION:A recombinant adenovirus vector expressing TbetaR-II extracellular domain-RANTES fusion gene has been constructed successfully. The recombinant adenovirus vector can bind TGF-beta1 effectively, counteract immune suppression mediated by TGF-beta, enhance immune function, induce significant antitumor immune respone, inhibit tumor growth, and prolong the survival time of tumor-bearing mice.

Study on the Construction of Recombinant AAV Vector Mediated Tumstatin Gene and Its Activity

Construction of Rav-Tumstatin Viral Vector and Detection of Its Bioactivty

CONSTRUCTION OF ADENO ASSOCIATED VIRUS RECOMBINANT PLASMID OF CONNECTIVE TISSUE GROWTH FACTOR AND ITS EXPRESSION IN HEK293 CELLS

Construction, Packaging and Titration of Recombinant Adeno-Associated Virus Vectors Contaning Antitumor Genes

Construction and Identification of Recombinant Adeno-Associated Virus Vector Harboring Fusion Gene NT4-Apoptin-HA2-TAT

Preparation of the Antiangiogenic Peptide Alphastatin Recombinant Adeno-Associated Virus

[The Construction of Recombinant AAV Vector Expressing HSVtk Gene Controlled by Tet-On and the Detection of Its Activity].

Construction of a recombinant adenovirus vector carrying human canstatin gene and adenovirus preparation

Construction and Identification of Adeno-Associated Virus Mediated Gene Transfer of TIMP-1

Construction of Recombinant Adenovirus for the Angiogenic Inhibitor,Vasostatin,and Its Expression in Vitro

Construction of Recombinant Adenovirus Harboring Fusion Gene NT4p53(C22)Ant and Its Killing Effect on HepG2 Tumor Cells

Construction of recombinant lentivirus vector containing retinoic acid-induced gene G and its effect on human lung cancer A549 cell line

Construction of Recombinant Lentivirus Vector for Tumor Vasoinhibitory Peptide Alphastatin Gene Delivery

[Construction of Recombinant Adenovirus Vector Expressing Extracellular Domain of TbetaR-II-RANTES Fusion Gene and Its Anti-Tumor Effects].

[A recombinant adeno-associated virus expressing secretory TGF-β type Ⅱ receptor inhibits triple-negative murine breast cancer 4T1 cell proliferation and lung metastasis in mice]

Construction and Expression of Recombinant Adenovirus Containing Human Thymic Stromal Lymphopoietin Gene

Construction and Expression of Regulated Human Tumor Suppressor Gene PTEN Recombinant Adenovirus Vector

Construction of Recombinant Adeno-Associated Virus Vector Co-Expressing Hvegf165 and Hbmp7 Gene

Establishment of A Recombinant Adeno-Associated Virus Expressing Hvegf(165)

[Construction of a Recombinant Adenoviral Vector Expressing Human Endostatin].

Construction of Recombinant Adenoviruse Vector Containing Tissue-Type Plasminogen Activator and Its Effect on the Expression of VEGF in the Transfected Active ECV304 Cells